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Abstract
Self-expandable metal stents are used for palliation of malignant biliary obstruction. A case with advanced carcinoma of the
pancreatic head and the need for palliative decompression of an obstructed biliary tract is demonstrated. Step-by-step
explanation of the stent placement procedure is provided. This article is part of an expert video encyclopedia.
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Technique
Endoscopic retrograde cholangiopancreatography (ERCP).
Materials
• Duodenoscope: ED 450XT8; Fujiﬁlm, Tokyo, Japan.
• Sphincterotome: PreCurved Triple Lumen sphincterotome;
Cook Medical, Winston-Salem, NC, USA
• Metal stent: Uncovered Niti-S stent, diameter 1 cm, length
6 cm; Taewong Medical Co., Ltd., Korea.
• Snare: Standard snare; Olympus, Tokyo, Japan.
Background and Endoscopic Procedure
A 83-year-old man with known nonresectable cancer of the
pancreatic head was admitted for exchange of a clogged biliary
plastic stent with a self-expandable metal stent. This inter-
vention is indicated because metal stents have a longer pa-
tency compared to plastic stents,1,2 with a median patency
period for expandable stents of approximately 10 months.
In our case, ERCP showed neoplastic inﬁltration of the
ampulla and periampullary region. Before stent retrieval, it is
important to have a close look at the exact position of the
papillary oriﬁce, because in cases with neoplastic ampullary
inﬁltration, identiﬁcation might be difﬁcult once the stent is
extracted. There are different techniques for stent retrieval. In
the present case, simplest method is used: the very distal end
of the stent is grasped with a snare and the stent is extracted. In
cases with anticipated difﬁculties in passage of malignant
stenoses, a ‘beside-the-wire’ technique is applied. This involves
cannulation of the bile duct alongside the indwelling stent
and passage of a guide wire across the stricture. After the guide
wire is positioned upstream from the stricture, the stent is
extracted with a snare, leaving the guide wire in place for
subsequent placement of a new stent. With this technique,
access to the duct is secured during the extraction procedure.
In the present case, the common bile duct (CBD) was easy
to cannulate. Injection of contrast media revealed a pre-
papillary high-grade stenosis with a length of 35 mm. The
delineation of the stenosis is smooth without irregularities,
suggesting a compression rather than an intraductal neoplasia.
In the proximal area of the stenosis, the CBD is dilated and
shows discrete irregularities suggestive of cholangitis. It is of
utmost importance to choose the optimal stent length. This is
done by simple addition of the distances. The stricture needed
to be bridged is 35 mm. The stent should extend 5–10 mm
beyond the papilla into the duodenum and extend 2–3 cm
proximal of the stenosis. Therefore, the optimal length of the
stent in our case is 7 cm. Keep in mind that metal stents
shorten after expansion and this has to be taken into con-
sideration when the stent length is being selected. However,
although this is a signiﬁcant concern for stainless steel metal
stents, shortening of nitinol stents occurs to a far lesser extent.
The technique for insertion of the self-expandable un-
covered nitinol stent (7 cm length, 1 cm diameter) is rather
simple. A 4 m-long guide wire is positioned through the
stenosis. The stent is deployed with the aid of an 8 Fr delivery
catheter with the constrained stent. This device is inserted
through the working channel over the guide wire and pos-
itioned at the midpoint of the stricture. Once it is in position,
the restraining mechanism is released, and the catheter ex-
pands to its predetermined diameter. The delivery catheter is
then withdrawn through the expanded stent. The yellow
marking of the delivery catheter signals the distal end of the
stent after expansion. During stent deployment, always keep
the marking positioned 5–10 mm in front of the papilla and
adjust the stent position if necessary. As a rule, during ex-
pansion it is easier to withdraw the stent than to advance it.
Once fully deployed, an expandable stent will be ﬁrmly an-
chored in the duct and difﬁcult to remove.
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What is the optimal stent position? Expandable stents in-
serted for distal CBD strictures should extend approximately
5–10 mm beyond the papilla into the duodenum. Extension
exceeding 2 cm can cause duodenal ulceration and perforation.
In contrast, for hilar strictures, the distal end of the stent is
usually positioned in the distal part of the bile duct. Placement
inside the duct may reduce the risk of clogging from food ﬁbers.
Key Learning Points/Tips and Tricks
• In cases with anticipated difﬁcult recannulation, use the
‘beside-the-wire’ technique for exchange of biliary stents.
• During stent deployment, the position of the stents needs
to be adjusted. The marking of the distal end should always
be in sight and positioned approximately 1 cm in front of
the papilla.
• Important for adjustment: it is easier to withdraw the stent
than to advance it.
Complications and Risk Factors
In malignant strictures, metal stents may occlude due to tumor
ingrowth or overgrowth or sludge. Bile duct and ulcerations
and perforations may occur, especially after maldeployment.
The high cost of expandable stents limits their application.
However, metal stents become cost effective in patients who
survive long enough to require an exchange of a blocked plastic
stent or with an estimated survival longer than three months.1
Alternatives
For malignant biliary tract stenosis, uncovered metal stents
over covered ones are preferred. It has been suggested that
uncovered metal stents may better prevent tumor ingrowth.
However, coating might cause occlusion of the cystic duct or
branches of the hepatic ducts. Moreover, coated stents are
more expensive and, importantly, have greater propensity to
migrate.3 A recent large randomized, multicenter trial showed
that there are no signiﬁcant differences in patency time, pa-
tient survival, or complication rates between covered and
uncovered nitinol metal stents.3
Scripted Voiceover
A 83-year-old man with known nonresectable cancer of the
pancreatic head was admitted for exchange of a clogged biliary
plastic stent with a self-expandable metal stent. At ERCP, we see
beginning neoplastic inﬁltration of the ampulla and peri-
ampullary region and a straight plastic stent within the bile
duct. Before we extract the stent, it is important to have a close
look at the exact position of the papillary oriﬁce, because in
cases with neoplastic inﬁltration, identiﬁcation might be dif-
ﬁcult once the stent is extracted. Now the very distal end of the
stent is grasped with a snare. Because the stent diameter does
not allow extraction through the instrumentation channel, the
endoscope is removed with the stent. Now we are back in
position. The duodenal lumen is compressed by the tumor and
does not allow adequate distance to the papilla for optimal
positioning of the endoscope. In this case, the sphincterotome
allows for a better angle for cannulating the bile duct. The
sphincterotome is bent and positioned in line with the bile
duct and then the guide wire is jiggled to pass through the
stricture. After successful insertion, the catheter can then follow
the guide wire and negotiate the stricture and be advanced
beyond the stricture. We can also spot massive calciﬁcations
within the pancreatic head, pointing to the known history of
chronic pancreatitis. Injection of contrast media reveals a pre-
papillary high-grade stenosis with a length of 35 mm. The de-
lineation of the stenosis is smooth without irregularities,
suggesting a compression rather than an intraductal neoplasia.
Proximal of the stenosis the bile duct is dilated and shows
discrete irregularities suggestive of cholangitis. The optimal
length of the stent is determined by simple addition of the
distances that need to be bridged. The stricture is 35 mm. The
stent should extend approximately 5–10 mm beyond the pa-
pilla into the duodenum and extend 2–3 cm proximal of the
stenosis. Therefore, in our case we choose an uncovered nitinol
stent with 7 cm length. Now we remove the sphincterotome
but leave the guide wire in place. The technique for insertion of
the self-expandable nitinol stent is rather simple. The stent is
deployed with the aid of an 8 Fr delivery catheter with the
constrained stent. This device is inserted through the working
channel over the guide wire. We advance the delivery catheter of
the Niti-S Taewong stent into the bile duct until we see a yellow
mark on the sheath. This mark is of utmost importance as it
identiﬁes the distal end of the stent. Here it is: Take special care
that this marking is always positioned 5–10 mm in front of the
papilla during the whole deployment procedure. At ﬂuoro-
scopic control, we see three ﬂuoroscopic markings that identify
the middle portion of the stent and the distal and proximal
ends. Once this optimal position is achieved, the restraining
mechanism is released, and the catheter expands to its pre-
determined diameter. During stent deployment, we have to
adjust the stent position if necessary to keep the yellow mark in
the desired place. As a rule, during expansion it is easier to
withdraw the stent than to advance it. By the way: Compared to
metal stents made from stainless steel, nitinol stents do not
shorten as much during expansion. This is an advantage. Once
fully deployed, the expandable stent will be ﬁrmly anchored in
the duct. Now the delivery catheter is withdrawn through the
expanded stent. This is the optimal stent position: Expandable
stents inserted for distal common bile duct strictures should
extend approximately 5–10 mm beyond the papilla into the
duodenum. Extension exceeding 2 cm can cause duodenal ul-
ceration and perforation. Fluoroscopic control conﬁrms com-
plete stent expansion with some narrowing at the level of the
stenosis.
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